PTAB Won't Review Chiesi Unit's 4 Hypertension Drug Patents
The Patent Trial and Appeal Board on Friday declined four separate bids by generic drug manufacturer Sandoz Inc. to review four patents owned by a Chiesi USA Inc. unit related to...To view the full article, register now.
Already a subscriber? Click here to view full article